🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Removal

According to TikTok, the service has taken down violative content and prohibited associated keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

After moments of entering one group, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how much time a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially significant medical dangers”.